Announcements Trials
Browse Landscape

Phase

Phase 2 101Phase 1 43Phase 1/2 38Phase 3 21Phase 2/3 7Phase EARLY_PHASE1 6Phase NA 4Phase 4 4

Status

Completed 7Recruiting 4Unknown 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1Dermatologic 1

Conditions

Kidney Neoplasms 2Carcinoma, Renal Cell 2Neoplasms 1Neoplasm Metastasis 1Melanoma 1

Interventions

Propofol 9Sevoflurane 7Rituximab 7Magnetic Resonance Spectroscopy 6Dexamethasone 6Trastuzumab 5Specimen Handling 5Enoxaparin 5Carboplatin 5Bevacizumab 5Nivolumab 4Capecitabine 4Bupivacaine 4trametinib 3pirtobrutinib 3dabrafenib 3atezolizumab 3apixaban 3Lenalidomide 3Indocyanine Green 3Gemcitabine 3Docetaxel 3Cyclophosphamide 3zanubrutinib 2venetoclax 2trastuzumab deruxtecan 2ribociclib 2polyethylene glycol 3350 2pertuzumab 2pembrolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Nivolumab × Clear all
NCT07028125 2026-06-05

CANIQOL

Centre Francois Baclesse

Phase 4 Recruiting
83 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT07504796 2026-04-21

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

NYU Langone Health

Phase 4 Recruiting
90 enrolled
Dermatologic

Melanoma

NCT06031233 2026-03-30

MINUTE

Isala

Phase 4 Recruiting
776 enrolled
Tumor-Agnostic

Neoplasms

NCT06934057 2025-09-24

CABOLD

Gustave Roussy, Cancer Campus, Grand Paris

Phase 4 Recruiting
50 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡